Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001920738-26-000004

Chief Legal Officer sold 6,566 shares at $14.00 ($91,924)

  • Chief Legal Officer acquired 6,566 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bizily Scott Chief Legal Officer 2026-06-30 Option exercise 10b5-1 +814 $4.14 $3,370 9,431 D: show line 1 in the form
Bizily Scott Chief Legal Officer 2026-06-30 Option exercise 10b5-1 +5,752 $6.49 $37,330 15,183 D: show line 2 in the form
Bizily Scott Chief Legal Officer 2026-06-30 Sale 10b5-1 −6,566 $14.00 $91,924 8,617 D: show line 3 in the form
Open-market sales · 6,566 sh · avg $14.00 · $91,924

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bizily Scott Chief Legal Officer 2026-06-30 Option exercise · Stock Option (Right to Buy) 10b5-1 −814 62,971 D: show line 4 in the form
Bizily Scott Chief Legal Officer 2026-06-30 Option exercise · Stock Option (Right to Buy) 10b5-1 −5,752 3,543 D: show line 5 in the form
Loading xslF345X06/ownership.xml…